期刊文献+

视网膜母细胞瘤中EphB4和EphrinB2的表达及意义 被引量:1

Expression of EphB4 and EphrinB2 in retinoblastoma and their significance
原文传递
导出
摘要 目的探讨EphB4和EphrinB2的蛋白在视网膜母细胞瘤中的表达及其意义。方法应用免疫组织化学SP法测定10例正常视网膜组织和40例视网膜母细胞瘤标本中EphB4和EphrinB2的表达水平,分析其与性别、临床分期、分化程度和视神经浸润的关系。结果(1)EphB4和EphrinB2蛋白表达的阳性率,在正常视网膜组织中分别为5%和2.5%,40例视网膜母细胞瘤标本中分别为77.5%和67.5%。EphB4和EphrinB2在视网膜母细胞瘤组织中的阳性率与显著高于正常视网膜组织中的阳性率(P〈0.05)。(2)EphB4和EphrinB2的蛋白在视网膜母细胞瘤的阳性表达率与肿瘤组织的临床分期、分化程度及视神经浸润显著相关(P〈0.05)。(3)EphB4和EphrinB2的蛋白在视网膜母细胞瘤组织中的阳性表达显著相关(P〈0.05)。结论EphB4和EphrinB2可能在视网膜母细胞瘤的发生和发展过程中起重要作用,可作为评价视网膜母细胞瘤的浸润及预后的标志物。 Objective To investigate the protein expressions of EphB4 and EphrinB2 in retinoblastoma and to study their significance. Methods The expression of EphB4 and EphrinB2 was examined immunohistochemistrically by SP method in tissues of 10 normal retina and 40 patients with retinoblastoma and to study their relationship with gender, clinical stage, differentiation and optic nerve infiltration. Results 1.The protein expression of EphB4 and EphrinB2 observed in the normal tissues of retina was 5% and 2.5% respectively. In the 40 retinoblastoma cases, the positive rate of them was 77.5% and 67.5% respectively. The positive rate of EphB4 and EphrinB2 in retinoblastoma was higher than that in the normal retina (P 〈0.05). 2.The positive expression of EphB4 and EphrinB2 protein were associated with clinical stage, differentiation and optic nerve infiltration (P 〈 0.05). 3.The positive expression of EphB4 and EphrinB2 protein in retinoblastoma was positively correlated (P 〈0.05). Conclusions EphB4 and EphrinB2 play important roles in carcinogenesis, development procedures of retinoblastoma and might be served as objective indicators of invasion and prog- nosis of retinoblastoma.
出处 《中国实用眼科杂志》 CSCD 北大核心 2012年第11期1321-1324,共4页 Chinese Journal of Practical Ophthalmology
关键词 EPHB4 EPHRINB2 视网膜母细胞瘤 免疫组织化学 EphB4 EphrinB2 Retinoblastoma Immunohistochemistry
  • 相关文献

参考文献13

  • 1曾一平,张晓农.视网膜母细胞瘤的临床病理及预后[J].中国实用眼科杂志,1997,15(2):99-101. 被引量:10
  • 2Stannard C, Lipner S, Sealy R.et al.Retinoblastoma: Correlation of Invasion of the optic nerve and choroids with prognosis and metastasis[J].Br J Ophthalmol,1979,63:560-570.
  • 3赵玉斌,张少华,张积仁,王政江.ER、PR和EphA2在乳腺癌中的表达及临床意义[J].实用肿瘤杂志,2010,25(1):41-44. 被引量:34
  • 4赵玉斌,张少华,王金清,蔡学海,纪维忠,张积仁.乳腺癌组织EphA2和EphrinA1蛋白表达及其临床意义的探讨[J].中华肿瘤防治杂志,2011,18(7):513-516. 被引量:12
  • 5Fox BP,Kandpal RP.Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecu- lar markers of potential diagnostic and prognostic application[J]. Biochem Biophys Res commun, 2004,318 (4) : 882-892.
  • 6Yang NY,Pasquale EB,Owen LB,et al.The EphB4 receptor-ty- rosine kinase promotes the migration of melanoma cells through Rho-mediated actin cyto-skeleton reorganization [J ].Biol Chem, 2006,281 (43) : 32574-32586.
  • 7Josep Castellvi; Angel Garcia; Javier de la Torre, et al.EphrinB expression in epithelial ovarian neoplasms correlates with tu- mor differentiation and angiogenesis [J].Hum Pathol, 2006, 37 (7) :883-889.
  • 8Meyer S,Hafner C,Guba M,et al.EphrinB2 Over-expression en- hances integriMediated ECM-attachment and migration of BI6 melanoma cells [J].International Journal of Oncology, 2005, 27 (5) : 1197-1206.
  • 9Sinha UK, Mazhar K, Chinn SB, et al.The association between elevated EphB4 expression, smoking status, and advanced stage disease in patients with head and neck squamous cell carcino- ma [Jl.Arch Otolaryngol Head Neck Surg, 2006, 132 (10) : 1053-1059.
  • 10王勇,刘益飞.视网膜母细胞瘤中Survivin和EphB4表达及意义[J].交通医学,2010,24(2):123-124. 被引量:2

二级参考文献39

  • 1韩丽萍,乔玉环,董子明,Jahn M.Nesland,索振河.激光捕获显微切割技术检测卵巢癌组织中EphA2受体的表达[J].郑州大学学报(医学版),2009,44(2):368-371. 被引量:2
  • 2韩丽萍,董子明,乔玉环,Jahn M.Nesland,索振河.卵巢癌组织中EphA2受体蛋白的表达[J].郑州大学学报(医学版),2005,40(2):308-311. 被引量:9
  • 3赵瑞皎,吴向华,石必枝,王华茂,李宗海.酪氨酸蛋白激酶受体EphA2及其配体EFNA1在23种肿瘤细胞系中的表达及其意义[J].中国癌症杂志,2007,17(4):320-323. 被引量:6
  • 4Zeng G, Hu Z, KinchM S, et al. High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia [ J ]. Am J Pathol,2003,163 (6) : 2271 - 2276.
  • 5Valladares A, Hernandez NG, Gomez FS, et al. Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women [ J]. Cancer Genet Cytogene,2006,170(2): 147- 151.
  • 6Yamaguchi S, Tatsumi T, Takeharat T, et al. Immunotherapy of routine colon cancer using receptor tyrosine kinase EphA2-derlved peptide-pulsed dendritic cell vaccines [ J ]. Cancer,2007,110(7) : 1469 - 1477.
  • 7Abraham S, Knappd W, Cheng L, et al. Expression of EphA2 and EphrinA-1 in carcinoma of the urinary bladder [ J]. Clin Cancer Res ,2006,12(2 ) :353 - 360.
  • 8Hessa R, Seftor EA, Gruman LM, et al. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenlcmimicry [ J ]. Cancer Biol Ther, 2006, 5 (2) :228 -233.
  • 9Wu D, Suo Z, Kristensen GB, et al. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma [ J ]. Gynecol Oncol, 2004,94 ( 2 ) : 312 - 319.
  • 10Zelinsld DP, Zantek ND, Walker-Daniels J, et al. Estrogen and Mye negatively regulate expression of the EphA2 tyrosine kinase [ J ]. Cell Biochem, 2002, 85 (4) :714 -720.

共引文献49

同被引文献19

  • 1Bethea C L, Reddy A P. Effect of ovarian steroids on gene expression related to synapse assembly in serotonin neurons of macaques[ J]. J Neurosci Res, 2012,90 ( 7 ) : 1324-1334.
  • 2Taylor A C, Mendel T A, Mason K E, et al. Peirce At- tenuation of ephrinB2 reverse signaling decreases vascu- larized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy [ J ]. Invest Ophthalmol Vis Sei, 2012,53 (9) :5462-5470.
  • 3Rushlow D E, Mol B M, Kennett J Y, et al. Characteri- sation of retinoblastomas without RB1 mutations: genom- ic, gene expression, and clinical studies [ J]. Lancet On- col, 2013,14(4) :327-334.
  • 4Liu R, Ferguson B D, Zhou Y, et al. EphBg as a thera- peutic target in mesothelioma[ J]. BMC Cancer, 2013,13 (26) :269.
  • 5Pennisi A, Ling W, Li X. The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth [ J ]. Blood, 2009,114 ( 9 ) : 1803-1812.
  • 6Krebs Luke T, Christa Chervonsky S, Alexander V, et al. Notchl Activation in Mice Causes Arteriovenous Mal- formations Phenocopied by EphrinB2 and EphB4 Mutants [ J ]. Genesis, 2010,48 ( 3 ) : 146-150.
  • 7王军友,杨学军,王国开.不同病理级别胶质瘤中EphB4和ephrinB2的表达[J].中国神经精神疾病杂志,2008,34(6):376-378. 被引量:3
  • 8杨光伦,涂刚,姚榛祥,岳俊伊.EphB4在乳腺浸润性导管癌中的表达及意义[J].第三军医大学学报,2009,31(5):438-440. 被引量:5
  • 9方晓亮(综述).EphB4受体和EphrinB2在前列腺癌中的作用及其与血管淋巴生成的关系[J].国际泌尿系统杂志,2009,29(2):194-197. 被引量:1
  • 10谢秋群,唐雄志,王世宣.EphB4受体及其配体ephrinB2与妇科肿瘤关系的研究进展[J].现代妇产科进展,2010,19(3):218-220. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部